Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results ...Middle East

CORAL GABLES, Fla., Aug. 11, 2022 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD) ("Relmada," the "Company," "we," "us, "our"), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update and announced preliminary...

Read More Details
Finally We wish PressBee provided you with enough information of ( Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results )

Also on site :

• Little Debbie's Surprising New Treat Leaks and Fans Want '15 of Them'
• Evacuations underway in Leander after home explosion
• ​6 months of LA-area wildfire recovery through the eyes of the Army Corps colonel on the frontlines